HPX and COVID-19: HPX has an anti-inflammatory effect by clearing hemolysis-related degradation products that induce inflammation and oxidative stress as well as acting as an inhibitor of hemolysis-induced complement activation and therefore has been proposed as a therapeutic agent in COVID-19 [42].